CompletedNot Applicable

Tranexamic Acid in Pregnancies With Vaginal Bleeding

Iraq139 participantsStarted 2016-02-01

Plain-language summary

Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage.

Who can participate

Age range18 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pregnant woman having vaginal bleeding * Second and third trimester of unknown etiology * No placenta previa, abruptio placentae, local cervical or vaginal causes for bleeding * Primigraivid, multiparous and grand multiparous woman * Accept to participate in the trial Exclusion Criteria: * Hypersensitivity to tranexamic acid * Women with acquired defective color vision * History of venous thromboembolism * Refused to participate

What they're measuring

Cessation of vaginal bleeding as self-reported by women

Timeframe: 7 days

Gestational age

Timeframe: up to 7 days postpartum

Rate of perinatal deaths

Timeframe: 7 dya after delivery

Neonatal Apgar(Appearance, Pulse, Grimace, Activity, and Respiration) score Apgar scores includes 10 sores , 2 for each . The Apgar score was classified as severely depressed <0-3>, moderately depressed<4-6> and excellent condition<7-10>

Timeframe: Up to fifth minutes of life

Trial details

NCT IDNCT03632824

SponsorHawler Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01-15

View on ClinicalTrials.gov More Vaginal Bleeding During Pregnancy trials